Marc Ferrante
- Genetics top 0.02%
- Inflammatory Bowel Disease 402
- Gastroenterology top 0.2%
- Celiac Disease Research and Management 44
- Epidemiology top 0.05%
- Microscopic Colitis 250
- Autoimmune and Inflammatory Disorders 43
- Immunology top 0.2%
- Immunodeficiency and Autoimmune Disorders 76
- Biosimilars and Bioanalytical Methods 33
- Surgery top 0.2%
- Eosinophilic Esophagitis 75
- Helicobacter pylori-related gastroenterology studies 37
- Co-authors
- Séverine VermeireGert Van AsschePaul RutgeertsMaja NomanVera BalletIngrid ArijsAnn GilsKristel Van Steen
- Cited by
- GeneticsGastroenterologyEpidemiology
- Journals
- Journal of Crohn s and Colitis (174 papers)Gastroenterology (102 papers)Inflammatory Bowel Diseases (39 papers)
- Partner nations
- BelgiumUnited StatesCanada
In The Last Decade
Marc Ferrante
503 papers receiving 21.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Genetics 12.4k
- Gastroenterology 1.6k
- Epidemiology 8.9k
- Immunology 4.7k
- Surgery 5.3k
Countries citing papers authored by Marc Ferrante
This map shows the geographic impact of Marc Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Ferrante more than expected).
Fields of papers citing papers by Marc Ferrante
This network shows the impact of papers produced by Marc Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Ferrante. The network helps show where Marc Ferrante may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc Ferrante, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 11 | |
| 13 | 2020 | 95 | |
| 14 | 2020 | 30 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 80 | |
| 17 | Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). | 2018 | 3 |
| 18 | Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD). | 2017 | 4 |
| 19 | Intestinal microbial signature predicts postoperative Crohn's disease recurrence following ileocaecal resection with ileocolonic anastomosis | 2015 | 1 |
| 20 | A panel of anti-glycan antibodies (gASCA, ALCA, ACCA and AMCA) in the diagnosis and differential diagnosis of IBD | 2006 | 1 |
About Marc Ferrante
Marc Ferrante is a scholar working on Genetics, Gastroenterology and Epidemiology, having authored 543 papers that have together received 21.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (402 papers), Microscopic Colitis (250 papers), Immunodeficiency and Autoimmune Disorders (76 papers), Eosinophilic Esophagitis (75 papers), Celiac Disease Research and Management (44 papers), Autoimmune and Inflammatory Disorders (43 papers), Helicobacter pylori-related gastroenterology studies (37 papers) and Biosimilars and Bioanalytical Methods (33 papers). The work is most often cited by research in Genetics (12.4k citations), Gastroenterology (1.6k citations) and Epidemiology (8.9k citations). Marc Ferrante has collaborated with scholars based in Belgium, United States and Canada. Frequent co-authors include Séverine Vermeire, Gert Van Assche, Paul Rutgeerts, Maja Noman, Vera Ballet, Ingrid Arijs, Ann Gils, Kristel Van Steen, Hans Clevers and Toshiro Sato. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.